What should you know about podoplanin immunohistochemistry?

Immunohistochemistry uses antibodies with visible labels to look for selected proteins in preserved tissue. Podoplanin staining can show a pattern and location of podoplanin in cells, which may help a pathologist compare possible tumour types or understand the tissue around a lesion. A stain is not a diagnosis by itself. The pathologist considers the cells' appearance, the tissue architecture, the strength and distribution of staining, and a panel of other markers. Positive or negative wording therefore needs to be read in the context of the biopsy and the question being investigated.

The stain is generally performed on tissue already collected during a biopsy or surgery, so it does not usually require a separate procedure. Ask whether enough tissue remains for additional tests and when the pathology report will be discussed. The result may help distinguish a tumour from another lesion, but imaging and clinical findings still matter. If the report uses terms such as focal, diffuse, weak, or strong staining, ask the pathologist or treating specialist to explain how that pattern affects the working diagnosis and next step.

After a biopsy, seek prompt advice for bleeding that does not settle, increasing redness or warmth, drainage, fever, worsening pain, or swelling at the procedure site. Seek urgent care for heavy bleeding, fainting, severe breathlessness, or sudden chest pain. A staining result is not an emergency, but a rapidly changing lump, severe pain, or new weakness should be reported while diagnostic planning continues.

Why was podoplanin selected for my tissue? Is the staining focal or widespread, and where is it located? Which other markers and microscopic features were considered? Does the result change the diagnosis, staging plan, or need for another biopsy? When will the full pathology findings be reviewed with me?